Browsing Centre for Cancer Prevention by Title
Now showing items 906-925 of 1181
-
A randomised comparison of different vaginal self-sampling devices and urine for human papillomavirus testing - Predictors 5.1.
(American Association for Cancer Research, 2021-01-29)BACKGROUND: HPV-based screening is rapidly replacing cytology as the cervical screening modality of choice. In addition to being more sensitive than cytology, it can be done on self-collected vaginal or urine samples. This ... -
A randomised trial comparing pain and ease of use of two different stabilising forceps for insertion of intrauterine contraception.
(2016-10)BACKGROUND: Pain at intrauterine contraception (IUC) fitting may be a deterrent for women and any reduction in discomfort would be likely to be beneficial to both women and clinicians. AIM: This study investigated the ... -
RANDOMISED TRIAL OF UNSELECTED BRCA TESTING IN ASHKENAZI JEWS: LONG TERM OUTCOMES AND FACTORS AFFECTING UPTAKE OF TESTING
(BMJ, 2019-11)Abstract from ESGO Annual Meeting Abstracts -
Rapid review of factors associated with flexible sigmoidoscopy screening use.
(2019-03)Flexible sigmoidoscopy (FS) screening has been shown to reduce colorectal cancer (CRC) incidence and mortality among screened adults. The aim of this review was to identify patient-related factors associated with the ... -
Rationale and design of the Prevent Anal Cancer Self-Swab Study: a protocol for a randomised clinical trial of home-based self-collection of cells for anal cancer screening.
(2021-06-29)INTRODUCTION: Squamous cell carcinoma of the anus is a common cancer among sexual minority men, especially HIV-positive sexual minority men; however, there is no evidenced-based national screening protocol for detection ... -
RAZOR: A Phase II Open Randomized Trial of Screening Plus Goserelin and Raloxifene Versus Screening Alone in Premenopausal Women at Increased Risk of Breast Cancer.
(2018-01)Background: Ovarian suppression in premenopausal women is known to reduce breast cancer risk. This study aimed to assess uptake and compliance with ovarian suppression using the luteinizing hormone releasing hormone (LHRH) ... -
Recommendations from the European Commission Initiative on Breast Cancer for multigene testing to guide the use of adjuvant chemotherapy in patients with early breast cancer, hormone receptor positive, HER-2 negative.
(Springer Nature, 2021-02-18)BACKGROUND: Predicting the risk of recurrence and response to chemotherapy in women with early breast cancer is crucial to optimise adjuvant treatment. Despite the common practice of using multigene tests to predict ... -
Reducing preventable adverse events in obstetrics by improving interprofessional communication skills - Results of an intervention study.
(2023-01-23)BACKGROUND: Progress in medicine involves the structured analysis and communication of errors. Comparability between the individual disciplines is only possible to a limited extent and obstetrics plays a special role: the ... -
The Refinement of Genetic Predictors of Multiple Sclerosis
(2014-05-02)